(ACA) Arcosa - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0396531008
ACA EPS (Earnings per Share)
ACA Revenue
ACA: Aggregates, Structures, Barges, Equipment, Materials
Arcosa Inc is a multifaceted infrastructure solutions provider catering to the US construction, engineered structures, and transportation sectors. The companys diversified portfolio is segmented into Construction Products, Engineered Structures, and Transportation Products, allowing it to tap into various markets, including residential and non-residential construction, infrastructure development, electricity transmission, wind power generation, and commercial marine transportation.
The Construction Products segment is a critical component, supplying essential materials and equipment such as aggregates, specialty materials, and construction site support equipment to the construction industry. Meanwhile, the Engineered Structures segment is a significant player in the production of utility structures, wind towers, and telecommunication structures, serving contractors, distributors, and government agencies. The Transportation Products segment rounds out the companys offerings with inland barges, fiberglass barge covers, and other marine equipment for the commercial marine transportation industry.
From a market perspective, Arcosas shares have demonstrated a relatively stable performance, with a current price of $89.94. Technical indicators suggest a potential upward trajectory, as the stock is trading above its 20-day and 50-day simple moving averages (SMA20: $87.67, SMA50: $82.47). However, the stock is below its 200-day simple moving average (SMA200: $92.01), indicating a possible resistance level. With an average true range (ATR) of 2.29, representing a 2.54% daily price movement, investors can expect moderate volatility.
Fundamentally, Arcosas market capitalization stands at $4.28 billion, with a price-to-earnings (P/E) ratio of 55.14 and a forward P/E of 23.31. The companys return on equity (RoE) is currently 3.21%, indicating room for improvement in terms of profitability. Considering the current valuation and growth prospects, a forecast can be made. Based on the technical data, a breakout above the SMA200 could signal a potential uptrend, while the fundamental data suggests that the company may need to improve its profitability to justify its current valuation. A potential price target could be around $105, representing a 17% increase from current levels, assuming the company can deliver improved earnings and maintain its market momentum.
Additional Sources for ACA Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
ACA Stock Overview
Market Cap in USD | 4,359m |
Sector | Industrials |
Industry | Engineering & Construction |
GiC Sub-Industry | Construction & Engineering |
IPO / Inception | 2018-10-30 |
ACA Stock Ratings
Growth Rating | 56.0 |
Fundamental | 10.7 |
Dividend Rating | 31.8 |
Rel. Strength | -10.8 |
Analysts | 4.83 of 5 |
Fair Price Momentum | 85.64 USD |
Fair Price DCF | 74.95 USD |
ACA Dividends
Dividend Yield 12m | 0.28% |
Yield on Cost 5y | 0.61% |
Annual Growth 5y | 0.00% |
Payout Consistency | 96.4% |
Payout Ratio | 7.2% |
ACA Growth Ratios
Growth Correlation 3m | 76.5% |
Growth Correlation 12m | -13.5% |
Growth Correlation 5y | 86.2% |
CAGR 5y | 16.37% |
CAGR/Max DD 5y | 0.45 |
Sharpe Ratio 12m | -0.15 |
Alpha | -10.60 |
Beta | 1.567 |
Volatility | 31.43% |
Current Volume | 237.9k |
Average Volume 20d | 178.6k |
As of June 20, 2025, the stock is trading at USD 87.00 with a total of 237,900 shares traded.
Over the past week, the price has changed by -0.81%, over one month by -0.98%, over three months by +6.40% and over the past year by +4.53%.
Neither. Based on ValueRay´s Fundamental Analyses, Arcosa is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 10.73 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ACA is around 85.64 USD . This means that ACA is currently overvalued and has a potential downside of -1.56%.
Arcosa has received a consensus analysts rating of 4.83. Therefor, it is recommend to buy ACA.
- Strong Buy: 5
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, ACA Arcosa will be worth about 96.9 in June 2026. The stock is currently trading at 87.00. This means that the stock has a potential upside of +11.41%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 111.8 | 28.5% |
Analysts Target Price | 111.8 | 28.5% |
ValueRay Target Price | 96.9 | 11.4% |